OEM/ODM Supplier Ivermectin Oral Solution For Veterinary Medicine - Enrofloxacin and Bromhexine Oral Solution – Jizhong
OEM/ODM Supplier Ivermectin Oral Solution For Veterinary Medicine - Enrofloxacin and Bromhexine Oral Solution – Jizhong Detail:
Enrofloxacine and Bromhexine HCl oral solution 20% + 1.5%
Compositions:
100ml contain:
Enrofloxacine…………………………..…..20g
Bromhexine HCl…………………………..1.5g
Excipients ad…………………………..100ml
Indications:
It is specially indicated for the treatment of infectious diseases of poultry, produced by gram positive bacterias, gram negative bacterias and/or mycoplasmas.
Usage and dosage:
For oral administration in drinking water.
Poultry: 25 ml of product in 100 litres of drinking water (10 mg/kg body weight) during 3 to 5 days.
Salmonellosins: 5 days.
Consult Veterinary Doctor in order to adjust dose according to the needs of the case to be treated and according to daily flock consumption.
Contraindications:
Anticoagulants, aluminum, cimetidine, xanthines in general. In cases of disorders in the central nervous system and in very young animals due to joint problems.
Withdrawal periods:
10 days
Do not administer in laying hens producing eggs for human consumption.
Package:
1 L/ bottle
Product detail pictures:
Related Product Guide:
All we do is usually connected with our tenet " Customer to start with, Rely on initial, devoting on the food packaging and environmental protection for OEM/ODM Supplier Ivermectin Oral Solution For Veterinary Medicine - Enrofloxacin and Bromhexine Oral Solution – Jizhong , The product will supply to all over the world, such as: Iran, Salt Lake City, Hungary, Our tenet is "integrity first, quality best". We have confidence in providing you with excellent service and ideal products. We sincerely hope we can establish win-win business cooperation with you in the future!
By Alberta from Kuwait - 2018.10.01 14:14
In general, we are satisfied with all aspects, cheap, high-quality, fast delivery and good procuct style, we will have follow-up cooperation!
By Mike from Boston - 2017.09.29 11:19